Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aspen Shares Climb After Drugmaker’s Earnings Growth Quickens
Bloomberg
Friday, August 29, 2014 - 10:15am
tags:
Aspen Pharmacare, earnings
Is Pfizer now eyeing up Actavis three months after failed AZ bid?
In-Pharma Technologist
Friday, August 29, 2014 - 8:12am
tags:
M&A, Actavis, Pfizer, AstraZeneca
Has Gilead Sciences, Inc.'s Star Drug Already Peaked?
Motley Fool
Friday, August 29, 2014 - 8:10am
tags:
Gilead Sciences, Sovaldi, hepatitis C
AstraZeneca buoyed by Pfizer takeover talks, colorectal cancer study for MEDI-4736
First Word Pharma
Friday, August 29, 2014 - 8:07am
tags:
colon cancer, AstraZeneca, Pfizer, M&A, MEDI-4736
Report: In a big split, Baxter looks to relocate biopharma to Boston
Fierce Biotech
Friday, August 29, 2014 - 8:04am
tags:
Baxter International, Boston
IRS struggles with device tax
Medical Marketing and Media
Friday, August 29, 2014 - 8:02am
tags:
device tax, devices, IRS
Eli Lilly and BI's Jardiance hits shelves
Medical Marketing and Media
Friday, August 29, 2014 - 8:00am
tags:
Eli Lilly, Jardiance, Boehringer Ingelheim, diabetes, SGLT2 inhibitor
Will Seattle Genetics (SGEN) Crush Estimates at Its Next Earnings Report?
Yahoo/Zacks.com
Friday, August 29, 2014 - 7:58am
tags:
Seattle Genetics, earnings
Johnson & Johnson Said Exploring Sale of Cordis Devices Business
Bloomberg
Friday, August 29, 2014 - 7:56am
tags:
JNJ, Cordis, devices, M&A
Consultants expect M&A tempo to continue
Medical Marketing and Media
Thursday, August 28, 2014 - 7:27pm
tags:
M&A
MediciNova Rises on FDA's Nod on MN-166 Study Initiation
Yahoo/Zacks.com
Thursday, August 28, 2014 - 7:25pm
tags:
FDA, MediciNova, MN-166, Lou Gehrig's disease, amyotrophic lateral sclerosis
Amgen: Why Its New Drug Application is a Big Deal
Barron's
Thursday, August 28, 2014 - 7:23pm
tags:
Amgen, evolocumab, PCSK9 inhibitors
AstraZeneca Pops on Possibility of Another Pfizer Bid
WSJ Online
Thursday, August 28, 2014 - 7:18pm
tags:
Pfizer, AstraZeneca, M&A
Takeda, Lilly Lose Bid to Overturn $9 Billion Actos Award
Bloomberg
Thursday, August 28, 2014 - 7:16pm
tags:
Actos, diabetes, Eli Lilly, Takeda
Does Pfizer still need AstraZeneca's vaccines business?
Fierce Vaccines
Thursday, August 28, 2014 - 11:08am
tags:
Pfizer, M&A, vaccines, AstraZeneca, Prevnar 13
Two new biotech IPOs help set the stage for the fall parade
Fierce Biotech
Thursday, August 28, 2014 - 11:04am
tags:
IPOs, Rhythm Pharmaceuticals, Dermira
Amgen submits U.S. application to sell cholesterol-fighting drug
Yahoo/Reuters
Thursday, August 28, 2014 - 10:28am
tags:
Amgen, PCSK9 inhibitors, evolocumab
Lilly's Returning Cash to Shareholders With Generous Dividend, Stock Buybacks
TheStreet.com
Thursday, August 28, 2014 - 10:22am
tags:
Eli Lilly, dividends
Aegerion says FDA investigation into off-label marketing is closed
Bizjournals.com
Thursday, August 28, 2014 - 10:10am
tags:
Aegerion, off-label, FDA
Frustrating Boston Scientific Is Not What the Investor Ordered
TheStreet.com
Thursday, August 28, 2014 - 10:05am
tags:
devices, Boston Scientific

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.